TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.

Philippe Armand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.